Which states require insurers to cover GLP-1s?
This is a fast-moving area of state law — most bills are proposals, not enacted mandates.
Sources last checked September 21, 2026
North Dakota became the first state to mandate GLP-1 insurance coverage, in January 2025. Since then, most state activity has been proposed legislation — many bills did not pass. Don't assume a headline about a bill means it became law in your state.
Enacted so far
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
First state mandate for GLP-1 insurance coverage (Jan 2025)
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
SB 25-048: large-group plans must offer the option to purchase GLP-1 coverage (not automatic/included)
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
Regulatory amendment covers GLP-1s under Medicaid with prior authorization and eligibility conditions
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
2025 law creates a study committee, not a coverage requirement
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
2026 law directs Medicaid to study cost savings — not a coverage requirement
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
2026 law authorizes the state to seek approval to add coverage to Medicaid — not yet active coverage
Status unconfirmed — verify before treating as enacted or failed
State legislative tracking sources don't always agree — these are still being confirmed.
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
AB 575 — as of its last recorded legislative action, only "amended in Assembly," not signed into law, despite some outlets describing it as enacted. Check CA Legislative Information (https://leginfo.legislature.ca.gov) directly.
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
HB 5038 / HB 5485 — sources conflict on whether this passed. Check Connecticut General Assembly bill status (https://www.cga.ct.gov) directly.
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
HB 2912 — reported as proposed; current status not independently confirmed.
Proposed, did not pass (as of last check)
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
SB 417 — would have mandated coverage
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
SB 193 — would have mandated coverage
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
HB 2412 — would have mandated coverage
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
HB 1332 — would have mandated coverage
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
SB 2867 — passed the legislature, vetoed
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
SSB 1138 — would require state employee plan review
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
HB 1197 / SB 5166 — would require agency reporting
A mandate isn't the only path to coverage — your specific employer plan matters more than your state in most cases.
Check Your Plan Directly →Source: Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025 and HealthInsurance.org state coverage tracker (general), 2026. State legislative sessions update constantly — verify current status before relying on this for a coverage decision.